Solid-phase Chemical Synthesis Mthod for Oligonucleotide
Origin of Solid-phase Chemical Synthesis Method
In the field of biology, the synthesis of DNA and RNA primarily relies on DNA/RNA polymerase enzymes. While the replication of DNA (as observed in techniques like the polymerase chain reaction) or RNA can be accomplished in substantial quantities through in vitro simulations, certain challenges arise. These include issues with sample purity, the requirement for specific templates during synthesis, and the complexity of introducing chemically modified nucleotides. In response to these challenges, researchers have embarked on investigating the creation of short-chain DNA/RNA molecules (referred to as oligonucleotides) exclusively through organic chemical processes, excluding the need for DNA/RNA polymerases and templates.
Fig.1 Synthesis of oligonucleotides on the solid phase. (Qiu, et al., 2013)
Key Technologies
Our synthesis platform is built on the robust and highly efficient phosphoramidite method, a solid-phase technique that is the industry standard for oligonucleotide production. This method involves anchoring the first nucleotide of the sequence to a solid support, which acts as a stable foundation for the growing chain. This approach allows for the use of excess reagents to drive each reaction to near-completion, while unreacted reagents and impurities can be simply washed away.
Solid-Phase Precision, Nucleotide by Nucleotide.
CD BioGlyco has a professional and constantly updated Glyco™ Synthesis Platform to provide Custom Carbohydrate Synthesis services for clients around the world, including Custom Sugar-nucleotides Synthesis, Custom Oligosaccharides Synthesis, Custom Polysaccharides Synthesis, and other high-quality services. At CD BioGlyco, we provide high-quality Oligonucleotide Synthesis services based on chemistry methods for clients. Chemistry method-based oligonucleotide synthesis techniques often require the use of controlled pore glass (CPG). CPG is covalently bonded to the 3'-OH of the initial nucleotide ribose through a linker, while the 2'-OH of ribose is protected with a protecting reagent. The 5'-OH is protected with dimethoxytrityl (DMT). In addition, adenine, guanine, and cytosine also require protection with acyl reagents (such as benzoyl) due to the presence of primary amino groups. The solid-phase synthesis service we provide mainly includes the following four steps.
- Deprotection
Use trichloroacetic acid (TCA) or dichloroacetic acid (DCA) dissolved in dichloromethane/toluene to remove the DMT group at the 5' ribose, exposing the 5'-OH for the next coupling step. Deprotection time depends on flow rate and column dimensions. - Coupling
The phosphoramidite monomer of the next nucleic acid reacts with the tetrazole to form a reactive intermediate. The 5'-OH formed during deprotection attacks the active intermediate nucleophile, then forms a new phosphorus-oxygen bond, and removes the tetrazole to extend the nucleotide chain. - Oxidation
After the coupling reaction, the newly added nucleotides are connected to the oligonucleotide chains on the CPG through trivalent phosphorus. The 2-cyanoethyl protecting group in the phosphodiester linkage makes the phosphite bond more stable in the subsequent synthesis. The commonly used oxidizing agent is tetrahydrofuran//pyridine/water solution of iodine. It is also converted to P (pentavalent) by transferring a sulfur atom to P (trivalent), thereby forming a phosphorothioate bond. - Capping
Since it is impossible to achieve 100% coupling efficiency, there are still 5'-OH active groups that have not reacted after deprotection. If not treated, these groups are still coupled in the next cycle to generate impurities. Two reagents are usually used (capping reagent A, usually acetic anhydride; capping reagent B, usually N-methylimidazole, the catalyst for the acylation reaction) to acylate the 5'-OH. Reagents A and B, stored separately, are mixed during the capping step and delivered to the system.
Workflow
Fig.2 Process of oligonucleotide synthesis by phosphoramidite method. (CD BioGlyco)
Publication Data
DOI.: 10.1016/j.bioorg.2023.106806
Journal: Bioorganic Chemistry
Published: 2023
IF: 4.7
Results: This review examines alternatives to traditional CPG supports for solid-phase oligonucleotide synthesis, focusing on scalability, efficiency, and purification challenges. The authors highlighted CPG's limitations for large-scale therapeutic oligonucleotide production, including low loading capacity and pore-size constraints. They systematically evaluated emerging approaches: liquid-phase oligonucleotide synthesis using soluble supports (e.g., cyclodextrins, branched PEGs, alkyl-chain systems), modified solid-phase polymer resins (e.g., polystyrene derivatives), functionalized CPG, and hybrid supports combining CPG with polymer coatings (e.g., HybCPG). The authors concluded that support choice is crucial for optimizing synthesis yield and purity, especially for industrial applications.
Applications of Solid-phase Chemical Synthesis Method
- The technology is helpful for the research on the synthesis of nucleic acid primers.
- The technology is applied in the field of nucleic acid probes, such as the rapid detection of viruses.
- The technology is applied in the development of nucleic acid medicines such as gene therapy.
Advantages of Us
- The technology allows the efficient synthesis of large numbers of oligonucleotide sequences.
- Oligonucleotides synthesized by the solid-phase synthesis technology are highly pure and specific. This is very important in genetic engineering and drug development.
- The technology allows the incorporation of artificially modified nucleic acids that do not occur in nature.
Frequently Asked Questions
Associated Services
To extend functionality for advanced therapeutic, diagnostic, and research applications, we offer specialized associated services enabling targeted modifications:
CD BioGlyco has first-class technology and well-trained technicians. Our dedicated team of experts works tirelessly to provide the Chemical-based Oligonucleotide Synthesis Service that meets clients’ needs and requirements. CD BioGlyco provides high-quality oligonucleotide synthesis services based on solid-phase chemical synthesis method, especially solid-phase phosphoramidite chemistry method. If you are interested in our services, please feel free to contact us for more details.
References
- Qiu, J.; et al. Solid phase click ligation for the synthesis of very long oligonucleotides. Chemical Communications. 2013, 49(62): 6959-6961. (Open Access)
- Brzezinska, J.; et al. From CPG to hybrid support: review on the approaches in nucleic acids synthesis in various media. Bioorganic Chemistry. 2023, 140: 106806. (Open Access)
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




